WO1998052567A1 - Method for treating headache pain with topical local anesthetic compositions - Google Patents
Method for treating headache pain with topical local anesthetic compositions Download PDFInfo
- Publication number
- WO1998052567A1 WO1998052567A1 PCT/US1997/008378 US9708378W WO9852567A1 WO 1998052567 A1 WO1998052567 A1 WO 1998052567A1 US 9708378 W US9708378 W US 9708378W WO 9852567 A1 WO9852567 A1 WO 9852567A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- local anesthetic
- composition
- topical
- target nerves
- headache pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/558,598 US5667799A (en) | 1995-10-30 | 1995-10-30 | Method for treating headache pain with topical local anesthetic compositions |
EP97926569A EP1003510A4 (en) | 1995-10-30 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
PCT/US1997/008378 WO1998052567A1 (en) | 1995-10-30 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
JP52798197A JP2001512415A (en) | 1997-05-20 | 1997-05-20 | Method for treating headache pain using a local local anesthetic composition |
AU31300/97A AU727736B2 (en) | 1997-05-20 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
CA002283929A CA2283929C (en) | 1997-05-20 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/558,598 US5667799A (en) | 1995-10-30 | 1995-10-30 | Method for treating headache pain with topical local anesthetic compositions |
PCT/US1997/008378 WO1998052567A1 (en) | 1995-10-30 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998052567A1 true WO1998052567A1 (en) | 1998-11-26 |
Family
ID=26792521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/008378 WO1998052567A1 (en) | 1995-10-30 | 1997-05-20 | Method for treating headache pain with topical local anesthetic compositions |
Country Status (3)
Country | Link |
---|---|
US (1) | US5667799A (en) |
EP (1) | EP1003510A4 (en) |
WO (1) | WO1998052567A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9370500B2 (en) | 2008-08-15 | 2016-06-21 | Centrexion Therapeutics Corporation | High concentration local anesthetic formulations |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
US6432986B2 (en) | 1997-07-21 | 2002-08-13 | Bruce H. Levin | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
US6103771A (en) * | 1998-03-20 | 2000-08-15 | Caldwell Galer Incorporated | Method of treating neuroma pain |
US6733794B1 (en) * | 1999-12-17 | 2004-05-11 | Edward L. Ingram | Topical composition for antiseptic and analgesic purposes |
US20070112052A9 (en) * | 2001-01-05 | 2007-05-17 | Larry Caldwell | Methods and compositions for treating headache pain with topical NSAID compositions |
US6528076B2 (en) | 2001-07-06 | 2003-03-04 | Magic Herb Corp. | Topical compositions and methods for treating pain |
US6894078B2 (en) * | 2001-09-17 | 2005-05-17 | James G. Castillo | Alcohol based topical anesthetic formulation and method |
US20030124174A1 (en) * | 2001-10-25 | 2003-07-03 | Endo Pharmaceuticals, Inc | Method for treating non-neuropathic pain |
US20060079558A1 (en) * | 2004-09-27 | 2006-04-13 | Bridge Pharma. Inc. | R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics |
WO2006036936A2 (en) * | 2004-09-27 | 2006-04-06 | Bridge Pharma, Inc. | The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents |
US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
US9427419B2 (en) * | 2005-09-12 | 2016-08-30 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (DMSO) |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
CA2655809C (en) * | 2006-07-21 | 2013-10-01 | Bridge Pharma, Inc. | Dermal anesthetic compounds |
PT2117521E (en) | 2006-11-03 | 2012-09-10 | Durect Corp | Transdermal delivery systems comprising bupivacaine |
WO2009026178A2 (en) * | 2007-08-17 | 2009-02-26 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
BRPI0921494A2 (en) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | method of planning a underground forming sampling operation, method of controlling a underground forming sampling operation, method of controlling a drilling operation for an underground formation, and method of sampling during the drilling operation. |
JP5947721B2 (en) | 2009-10-30 | 2016-07-06 | アベラ ファーマスーティカルズ インコーポレイテッド | Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations for treating osteoarthritis |
EP3226972A4 (en) | 2014-12-01 | 2018-08-08 | Achelios Therapeutics, Inc. | Methods and compositions for treating migraine and conditions associated with pain |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440777A (en) * | 1981-07-07 | 1984-04-03 | Merck & Co., Inc. | Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
US4466973A (en) * | 1983-02-01 | 1984-08-21 | Thomas Rennie | Method of treating nasal and sinus congestion |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4963591A (en) * | 1985-12-16 | 1990-10-16 | Carter-Wallace Inc. | Cosmetic compositions |
US4911707A (en) * | 1987-02-13 | 1990-03-27 | Ciba-Geigy Corporation | Monolithic user-activated transdermal therapeutic system |
AU622162B2 (en) * | 1988-04-22 | 1992-04-02 | Ciba-Geigy Ag | Transdermal monolith systems |
US5070084A (en) * | 1990-02-26 | 1991-12-03 | Campbell James N | Treatment of sympathetically maintained pain |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
JP2849950B2 (en) * | 1990-11-30 | 1999-01-27 | 日東電工株式会社 | Transdermal formulation |
US5401728A (en) * | 1992-04-02 | 1995-03-28 | Simon; John A. | Lecithin based topical liniment |
US5330452A (en) * | 1993-06-01 | 1994-07-19 | Zook Gerald P | Topical medicating device |
-
1995
- 1995-10-30 US US08/558,598 patent/US5667799A/en not_active Expired - Lifetime
-
1997
- 1997-05-20 EP EP97926569A patent/EP1003510A4/en not_active Withdrawn
- 1997-05-20 WO PCT/US1997/008378 patent/WO1998052567A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440777A (en) * | 1981-07-07 | 1984-04-03 | Merck & Co., Inc. | Use of eucalyptol for enhancing skin permeation of bio-affecting agents |
US4466973A (en) * | 1983-02-01 | 1984-08-21 | Thomas Rennie | Method of treating nasal and sinus congestion |
Non-Patent Citations (2)
Title |
---|
DATABASE CA ON STN, AMERICAN CHEMICAL SOCIETY, (Columbus, Ohio, USA), No. 126:162284 CA, "Local Anesthetics for Topical Treatment of Headache"; & EP,A,754 453 (LIEDTKE R.K.) 22 Jan. 1997. * |
See also references of EP1003510A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9370500B2 (en) | 2008-08-15 | 2016-06-21 | Centrexion Therapeutics Corporation | High concentration local anesthetic formulations |
US10758502B2 (en) | 2008-08-15 | 2020-09-01 | Centrexion Therapeutics Corporation | High concentration local anesthetic formulations |
US11517546B2 (en) | 2008-08-15 | 2022-12-06 | Centrexion Therapeutics Corporation | High concentration local anesthetic formulations |
Also Published As
Publication number | Publication date |
---|---|
US5667799A (en) | 1997-09-16 |
EP1003510A4 (en) | 2002-06-26 |
EP1003510A1 (en) | 2000-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5667799A (en) | Method for treating headache pain with topical local anesthetic compositions | |
US6673363B2 (en) | Transdermal and topical administration of local anesthetic agents using basic enhancers | |
US4746515A (en) | Skin permeation enhancer compositions using glycerol monolaurate | |
US4568343A (en) | Skin permeation enhancer compositions | |
CA2528360A1 (en) | Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine | |
US5519046A (en) | Ketorolac-containing fomentation | |
EP0857488A1 (en) | Methods and compositions for enhancing skin permeation of drugs using permeation enhancers | |
EP0857488A3 (en) | Methods and compositions for enhancing skin permeation of drugs using permeation enhancers | |
US20080045553A1 (en) | Transdermal Administration of Phycotoxins | |
CA1238275A (en) | Menthol enhancement of transdermal drug delivery | |
US20020192243A1 (en) | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers | |
US7273887B1 (en) | Topical anesthetic formulation | |
WO2004000268A1 (en) | Topical administration of pharmacologically active bases in the treatment of warts | |
US6953590B1 (en) | Tape material for transcutaneous absorption | |
US20070207088A1 (en) | Anti-Inflammatory Analgesic Adhesive Patch | |
US20070093555A1 (en) | Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
CA2322745C (en) | Method of treating neuroma pain | |
AU727736B2 (en) | Method for treating headache pain with topical local anesthetic compositions | |
JP2006298934A (en) | Method for treating pain of headache by using topical local anesthetic composition | |
AU2003298710B2 (en) | Composition and its use for treating neuropathic sensory loss | |
US20050112183A1 (en) | Compositions and methods for treating neuropathic sensory loss | |
US5183665A (en) | Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same | |
US4834980A (en) | Transdermal delivery of azatidine | |
JPH0331217A (en) | Percutaneous absorption promoting composition and external preparation containing same composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2283929 Country of ref document: CA Ref country code: CA Ref document number: 2283929 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 527981 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997926569 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997926569 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997926569 Country of ref document: EP |